Search clinical trials for: SER100

Total 88 results

Serenity Pharmaceuticals, Inc.

Completed

Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia

Nocturia

United States
Serodus ASA
The Research Council of Norway; Smerud Medical Research International AS

Completed

SER100 in Isolated Systolic Hypertension

Isolated Systolic Hypertension

United Kingdom, Finland, Hungary, Norway
Serenity Pharmaceuticals, Inc.

Completed

Multicenter Study to Investigate SER120 Nasal Spray Formulations in Patients With Nocturia - DB4 (DB4)

Nocturia

United States
Serenity Pharmaceuticals, Inc.

Completed

Treatment of Patients With Nocturia

Nocturia

United States
Serenity Pharmaceuticals, Inc.

Completed

Treatment of Patients With Nocturia (Non-PK Study)

Nocturia

United States
Serenity Pharmaceuticals, Inc.

Completed

Study to Investigate the Safety and Pharmacokinetics of SER120 Nasal Spray in Elderly Patients With Nocturia

Nocturia

United States
Serodus AS

Recruiting

SER150 vs Placebo in Diabetic Kidney Disease

Diabetic Kidney Disease

Australia, New Zealand
Montclair State University

Completed

Effects of Incorporating Sprouted and Non-sprouted Chickpea Flour in Pasta Products Analyzed in Vivo Flow-mediated Dilation

Endothelial Dysfunction
Noden Pharma

Completed

52-104 Week Off-therapy Second Extension to Study CSPP100A2365

Hypertension

Turkey, United States, Guatemala, Slovakia, Hungary, Puerto Rico, Poland
Novartis

Completed

A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US)

Hypertension

Switzerland
Nuwacell Biotechnologies Co., Ltd.
Shanghai 6th People's Hospital; Beijing Luhe Hospital

Not yet recruiting

A Trial to Evaluate the Safety, Tolerability, and Efficacy of NCR100 Injection in the Treatment of Subjects With KOA (NCR100)

Knee Osteoarthritis
Novartis

Completed

Pharmacokinetics, Safety and Tolerability of Aliskiren (SPP100) in Patients With End Stage Renal Disease on Hemodialysis and Matched Healthy Subjects

End Stage Renal Disease

Germany
Serenity Pharmaceuticals, Inc.

Completed

Long Term Safety Assessment of SER120 in Patients With Nocturia

Nocturia

United States
Ryvu Therapeutics SA

Recruiting

Safety and Efficacy of RVU120 for Treatment of Relapsed/Refractory AML (RIVER-52)

Acute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome

Poland
GCP-Service International West GmbH
Saint-Louis Hospital, Paris, France; University of Florence; Medical University... and other collaborators

Not yet recruiting

RVU120 for Treatment of Anemia in Patients With Lower-risk Myelodysplastic Neoplasms ((MDS))

Low Risk Myelodysplastic Syndromes

Spain, Poland, Italy, Germany, France
Sorriso Pharmaceuticals, Inc.

Recruiting

A Clinical Trial to Assess the Safety of SOR102 in Healthy Participants and Patients With Ulcerative Colitis

Ulcerative Colitis

Ukraine, Georgia
Peking University Cancer Hospital & Institute

Recruiting

To Explore the Efficacy and Safety of Camrelizumab Combined With SHR1020 in the Treatment of Advanced Melanoma

Melanoma

China
Meiji Seika Pharma Co., Ltd.

Completed

Pharmacokinetics and Safety Study of ME1100 in Healthy Volunteers

Healthy

United States
Stanford University

Completed

Evaluating Safety and Efficacy of Herbal Treatment in Ulcerative Colitis (SA100)

Ulcerative Colitis

United States
Ryvu Therapeutics SA

Active, not recruiting

RVU120 in Patients With Acute Myeloid Leukemia or High-risk Myelodysplastic Syndrome

Acute Myeloid Leukemia | High-risk Myelodysplastic Syndrome

United States, Poland
Novartis

Completed

Pharmacokinetic and Pharmacodynamic Profiles of Aliskiren in Japanese Patients With Mild to Moderate Essential Hypertension

Hypertension

Japan
Novartis

Completed

Study to Assess the Optimal Renoprotective Dose of Aliskiren in Hypertensive Patients With Type 2 Diabetes and Incipient or Overt Nephropathy

Diabetes Mellitus, Type 2

Denmark
University Medical Center Groningen

Terminated

Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment (ARIANA-CHF-RD)

Heart Failure | Kidney Failure

Netherlands
Norgine

Completed

Performance of NER1008 Enema Compared With Fleet® Enema in Bowel Cleansing

Colorectal Cancer

United Kingdom
Novartis Pharmaceuticals

Terminated

Efficacy of Aliskiren in the Treatment of Diabetic Macular Edema

Diabetic Macular Edema

Denmark, United States
Royal Free Hospital NHS Foundation Trust
Acurable Ltd.

Recruiting

AcuPebble to Remotely Monitor Patients With OSA on CPAP Therapy

Sleep Apnea, Obstructive

United Kingdom
Novartis Pharmaceuticals

Active, not recruiting

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients (STAND)

Sickle Cell Disease (SCD)

United States, United Kingdom, Germany, Spain, Greece, Italy, Brazil, Lebanon, Turkey, Belgium, France, Jordan, India, Finland, Canada, Colombia, Netherlands, Oman, South Africa, Panama, Ghana
Centagen, Inc.

Completed

Effects of a 10 Component Dietary Supplement on Health and the Quality of Life

Quality of Life | Stress | Blood Pressure | Joint Instability | Immune Deficiency | Lung Function Decreased | HDL Low | Energy Supply; Deficiency | Concentration Ability Impaired

United States
Norgine

Completed

Multicenter Randomized Parallel Group Phase III Study Comparing the Bowel Cleansing Efficacy, Safety and Tolerability of NER1006 Versus Trisulfate Solution Using 2-Day Split-Dosing Regimen in Adults (NOCT)

Colon Cancer | Colorectal Carcinoma | Colon Cleansing

United States
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Safety and Efficacy of Crizanlizumab in Sickle Cell Disease Related Priapism (SPARTAN)

Priapism

United States
Novartis Pharmaceuticals

Recruiting

Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study

Sickle Cell Disease

Belgium, Spain, Lebanon, United States, Brazil, France, Italy, Oman, Turkey, Germany, Colombia
Novartis Pharmaceuticals

Completed

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure (ASTRONAUT)

Acute Decompensated Heart Failure | Congestive Heart Failure

Colombia, Czech Republic, India, Italy, Belgium, Turkey, Argentina, France, Germany, Israel, Spain, Canada, Taiwan, United States, Singapore, Russian Federation, Philippines, Slovakia, Sweden, Hungary, Finland, Poland, Romania, Brazil
Norgine

Completed

Pharmacodynamic and Clinical Evaluation of Dose and Taste-optimised Low Volume PEG-based Bowel Cleansing Solutions Using the Split-dosing Intake Regimen in Healthy Subjects and in Subjects Undergoing Screening Colonoscopy

Colon Cancer

Germany
Novartis Pharmaceuticals

Active, not recruiting

Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients (ADORE)

Myelofibrosis

United Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
Norgine
Pierrel Research Europe GmbH

Completed

Pharmacodynamic Evaluation of Stool Output Following Oral Administration of Various Low Volume PEG3350-based Gut Cleansing Solutions Using the Split Dose Intake in Healthy Subjects (OUT)

Colorectal Cancer

Romania
Novartis

Completed

Hemodynamic Effects of Aliskiren Compared to Captopril on the Kidney in Healthy Volunteers on a Low- and High- Sodium Diet

Hypertension

United States
Ryvu Therapeutics SA

Recruiting

Safety and Efficacy of RVU120 Combined With Venetoclax for Treatment of Relapsed/Refractory AML

Acute Myeloid Leukemia

Italy, Poland
Bruin Biometrics, LLC

Completed

Evaluation of the SEM Scanner 200 for the Detection of Early Pressure Ulcers: A Multi-Site Longitudinal Study

Pressure Ulcers

United States
Novartis Pharmaceuticals

Recruiting

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

Sickle Cell Disease (SCD)

Germany, Spain, Belgium, Italy, Lebanon, United States, Brazil, Canada, Colombia, Oman, Switzerland, Turkey, United Kingdom, India, France
Novartis Pharmaceuticals

Available

MAP to Provide Access to Crizanlizumab, for Sickle Cell Disease Patients

Sickle Cell Disease
Norgine
Quotient Sciences

Completed

A Pharmacokinetic Study of PLENVU® in Healthy Subjects (PKPU)

Pharmacokinetic

United Kingdom
Myomo

Unknown

Myomo e100 NeuroRobotic System Home Safety Study

Stroke

United States
Novartis Pharmaceuticals

Completed

Study Exploring the Effect of Crizanlizumab on Kidney Function in Patients With Chronic Kidney Disease Caused by Sickle Cell Disease (STEADFAST)

Sickle Cell Disease (SCD)

United Kingdom, Spain, Greece, Brazil, Turkey, France, United States, Netherlands, Lebanon, Ireland, Panama
Myomo

Completed

Wearable Robotic Functional Assistance for Stroke Rehabilitation

CVA (Cerebrovascular Accident)

United States
Novartis Pharmaceuticals

Completed

An Indian Multi-centric Phase IV Study to Assess the Safety of Crizanlizumab in Sickle Cell Disease Patients

Sickle Cell Disease (SCD)

India
Meiji Seika Pharma Co., Ltd.

Completed

Intrapulmonary Pharmacokinetics of ME1100 in Healthy Volunteers

Healthy

United States
Taipei Veterans General Hospital, Taiwan
Apollo Medical Optics, Ltd

Completed

The Application of Non-invasive and Cellular Level Resolution Fullfield Optical Coherence Tomography: Establishment and Analysis of Subcutaneous Cellular Level Image Database of Anatomical Locations in Healthy Volunteers and Evaluation of Usability

Nevus | Healthy Skin

Taiwan
Neonc Technologies, Inc.

Recruiting

NEO100 and High-Grade Meningioma

Residual, Progressive or Recurrent Grade II or III Meningioma

United States
University of California, San Francisco
H. Lee Moffitt Cancer Center and Research Institute

Terminated

Valproic Acid in Combination With FEC100 for Primary Therapy in Patients With Breast Cancer (VPA-FEC100)

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Pharmacokinetics and Pharmacodynamics Study of SEG101 (Crizanlizumab) in Sickle Cell Disease (SCD) Patients With Vaso- Occlusive Crisis (VOC)

Sickle Cell Disease (SCD)

United States

Search clinical trials for: SER100

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations